Business Context and Reporting Period
Company: iBio, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: March 19, 2020
Event: Entry into a Material Definitive Agreement (Equity Line of Credit).
Key Financial Metrics and Transaction Terms
This filing details a financing arrangement rather than periodic financial performance metrics (revenue, profit, cash flow). Key transaction terms include:
- Total Commitment: Up to $50,000,000 in common stock over a 36-month term.
- Counterparty: Lincoln Park Capital Fund, LLC.
- Regular Purchase Limit: Up to 1,000,000 shares per trading day, with a maximum obligation of $5,000,000 per purchase.
- Pricing: Based on prevailing market price; no upper price limit, but subject to a floor price defined in the agreement.
- Initial Consideration: 815,827 shares of common stock issued to Lincoln Park upon execution.
- Exchange Cap: Issuance limited to 19.99% of outstanding shares (20,288,840 shares) without shareholder approval.
- Beneficial Ownership Cap: Lincoln Park cannot acquire more than 9.99% of outstanding shares.
Material Changes and Unusual Items
The primary material change is the establishment of an "at-the-market" equity facility. The filing does not report changes in revenue, operating margins, or debt levels. The agreement prohibits the Company from entering into any "Variable Rate Transaction" during the term.
Guidance, Outlook, and Management Commentary
- Use of Proceeds: Net proceeds will be used for working capital and general corporate purposes.
- Flexibility: The Company controls the timing and amount of sales. There are no trading volume requirements or restrictions.
- Termination: The Company may terminate the agreement at any time without fee, penalty, or cost.
- Outlook: Actual proceeds depend on market conditions and the Company's determination of funding needs.
Investor Verification Checklist
- Verify the specific "floor price" and "threshold price" definitions in the attached Purchase Agreement (Exhibit 10.1) to understand downside protection.
- Confirm the current number of outstanding shares to calculate the remaining capacity under the 19.99% Exchange Cap.
- Review the Company's most recent 10-Q or 10-K for actual cash burn rates to assess the necessity of this facility.
- Check for any subsequent filings indicating the first drawdown under this agreement.